Gardner, KS, United States of America

Roy A Jensen


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Roy A. Jensen: Pioneering Advances in Cancer Treatment

Introduction

Roy A. Jensen, based in Gardner, Kansas, has made significant contributions to the field of cancer treatment through his innovative work. With one patent to his name, he has focused on developing pharmaceutical compositions to treat, inhibit, and prevent breast and ovarian cancers. His dedication to advancing medical science and improving patient outcomes has led to important discoveries in therapeutic methodologies.

Latest Patents

Jensen's notable patent is centered around BRCA1-based breast or ovarian cancer treatment agents and methods of use. This patent details a pharmaceutical composition that includes a molecule, structured as one of Compounds 1-38, or a pharmaceutically acceptable salt or analog thereof. The composition is designed to be delivered using various administration methods, including oral, systemic, transdermal, intranasal, and parenteral, among others. The innovative aspect of this patent lies in the use of compounds that work therapeutically to effectively treat and prevent breast and ovarian cancers, as well as enhance the production of BRCA1.

Career Highlights

Roy A. Jensen works with the esteemed University of Kansas, where he engages in cutting-edge research and innovative applications in the medical field. His role at the university has allowed him to combine academic inquiry with practical solutions for pressing health issues, especially in oncology.

Collaborations

During his tenure at the University of Kansas, Jensen has collaborated with notable colleagues, including Lisa M. Harlan-Williams and Frank John Schoenen. These partnerships have fostered an environment of innovation and teamwork, leading to significant research advancements and the potential for new treatment methodologies.

Conclusion

In conclusion, Roy A. Jensen's work as an inventor and researcher is making waves in the field of cancer treatment. His patent reflects a commitment to improving health outcomes for individuals facing breast and ovarian cancers. Through collaboration and innovation, Jensen continues to contribute to the vital work of developing effective therapies and advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…